TABLE 2.
Changes in specific IgE Ab titers (ICT) in group E (progressive toxoplasmosis; 10 patients, 40 sera)
| Patient | ICT-E titer (/12)a at mo:
|
|||||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 6 | >6 | |
| 1 | 12 | 12 | NDb | 12 | 12 | 12 |
| 2 | 12 | ND | 12 | ND | ND | 12 |
| 3 | 6 | ND | ND | 4 | ND | ND |
| 4 | 12 | 8.5 | ND | 8 | ND | 0 |
| 5c | 10 | 12 | ND | ND | 4 | ND |
| 6c | 12 | 12 | ND | ND | 5 | 3 |
| 7 | 12 | 9 | 9.5 | 12 | 12 | ND |
| 8 | 12 | ND | ND | ND | 5 | ND |
| 9c | 12 | ND | ND | 11 | 6 | ND |
| 10 | 12 | ND | 2 | ND | 3.5 | ND |
a
Agglutination score. For adults, an IgM score of ≥9 is positive and an IgA or IgE score of ≥2 is positive.
b
ND, not done.
c
Patient with cervical adenopathy at the time of seroconversion.